Attach to Form 990 or Form 990-EZ.
Information about Schedule A (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.
| (i)Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 9 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
| Total | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2011 | (b) 2012 | (c) 2013 | (d) 2014 | (e) 2015 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any unusual grants.) .... | 34,135,315 | 55,590,601 | 40,345,846 | 33,315,225 | 38,374,895 | 201,761,882 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | 34,135,315 | 55,590,601 | 40,345,846 | 33,315,225 | 38,374,895 | 201,761,882 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | 7,927,395 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 193,834,487 | |||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2011 | (b) 2012 | (c) 2013 | (d) 2014 | (e) 2015 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 34,135,315 | 55,590,601 | 40,345,846 | 33,315,225 | 38,374,895 | 201,761,882 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 1,753 | 3,388 | 4,222 | 3,819 | 3,881 | 17,063 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10. | 201,778,945 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2011 | (b) 2012 | (c) 2013 | (d) 2014 | (e) 2015 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose...... | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 6 | Total. Add lines 1 through 5. | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons... | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2011 | (b) 2012 | (c) 2013 | (d) 2014 | (e) 2015 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by .035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | ||
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
||
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | ||
| 4 Amounts paid to acquire exempt-use assets | ||
| 5 Qualified set-aside amounts (prior IRS approval required) | ||
| 6 Other distributions (describe in Part VI). See instructions | ||
| 7Total annual distributions. Add lines 1 through 6. | ||
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
||
| 9 Distributable amount for 2015 from Section C, line 6 | ||
| 10 Line 8 amount divided by Line 9 amount | ||
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2015 |
(iii) Distributable Amount for 2015 |
|
|---|---|---|---|---|
|
1
Distributable amount for 2015 from Section C, line 6 |
||||
|
2
Underdistributions, if any, for years prior to 2015 (reasonable cause required--see instructions) |
||||
| 3 Excess distributions carryover, if any, to 2015: | ||||
| a | ||||
| b | ||||
| c | ||||
| d From 2013....... | ||||
| e From 2014....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2015 distributable amount | ||||
|
i
Carryover from 2010 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from 3f. | ||||
| 4Distributions for 2015 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2015 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from 4. | ||||
|
5
Remaining underdistributions for years prior to 2015, if any. Subtract lines 3g and 4a from line 2 (if amount greater than zero, see instructions) |
||||
|
6
Remaining underdistributions for 2015. Subtract lines 3h and 4b from line 1 (if amount greater than zero, see instructions) |
||||
|
7 Excess distributions carryover to 2016. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a | ||||
| b | ||||
| c Excess from 2013....... | ||||
| d From 2014....... | ||||
| e From 2015....... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | 15000290 |
| Software Version: | 15.3.0.0 |
Attach to Form 990 or 990-EZ.
Information about Schedule O (Form 990 or 990-EZ) and its instructions is at| Return Reference | Explanation |
|---|---|
| Form 990, Part I, Line 1 | The American Diabetes Association Research Foundation, Inc. the Foundation secures major gifts and grants to fund diabetes-related research. |
| Form 990, Part III, Line 4 Continued | 75 Years of Progress in the Fight Against Diabetes |
| Form 990, Part III, Line 4 Continued | Did you know that in the United States, diagnosed diabetes has increased by 350 percent in the last 30 years Thats 1.4 million Americans diagnosed every year. Diabetes literally touches everyone. It is dangerous, invasive and unrelenting. Its a chronic disease that spans all ages and walks of life, but targets children, the elderly and minority populations more than others. It costs the United States billions of dollars each year in lost productivity. It is a global epidemic. |
| Form 990, Part III, Line 4 Continued | Today nearly 30 million adults and children in the U.S. have diabetes - nearly 10 percent of the population. To make matters worse, 8.1 million of those 30 million dont even know that they have the disease. And yet another troubling trend is emerging. Type 2 diabetes, whose risk factors include a sedentary lifestyle and being overweight, is seen increasingly in children. In fact, between 2002 and 2009, there was a 35 percent increase in type 2 among adolescents. Research suggests that type 2 diabetes behaves differently in children than in adults - progressing more rapidly and aggressively. |
| Form 990, Part III, Line 4 Continued | The American Diabetes Association is the only organization dedicated specifically to the research, education and advocacy required to improve the lives of all Americans with diabetes. For 75 years, we have been working on the frontlines to educate at-risk populations, protect the rights of people with diabetes at work, school and other aspects of daily life, pioneer clinical and research breakthroughs and foster a pipeline of the best and brightest scientists. From research labs to the halls of the Capitol to the offices of health care practitioners to communities nationwide, we are there. We envision a life free of diabetes and all its burdens, which is fueled by our mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. |
| Form 990, Part III, Line 4 Continued | Diabetes Research |
| Form 990, Part III, Line 4 Continued | Accelerating Progress toward the Next Big Discovery |
| Form 990, Part III, Line 4 Continued | Diabetes is an extremely complex disease, caused by a combination of various genetic and environmental factors that progressively lead to an inability to produce or effectively utilize insulin. The complexity of causes conspiring to diminish the bodys production or response to insulin, leading to high blood glucose and eventual development of diabetes, makes finding a single cure particularly difficult. While a cure has been elusive, critical research efforts in recent decades have led to significantly improved patient care, resulting in fewer complications and better health outcomes for individuals with diabetes. |
| Form 990, Part III, Line 4 Continued | As a leader in diabetes research, and the only organization dedicated specifically to the research, education and advocacy required to improve the lives of all people with diabetes, the American Diabetes Association funds critical, innovative diabetes research and invests in promising scientists early in their careers. Our direct involvement in diabetes research extends back to the 1940s when Dr. Charles H. Best, one of four scientists credited with discovering insulin, provided the Association with the framework and early leadership for a formalized diabetes research program. |
| Form 990, Part III, Line 4 Continued | Since our Research Programs inception in 1952, we have been the leader in funding cutting-edge diabetes research, supporting nearly 4,500 research projects and investing more than 735 million in diabetes research. In 2015, the Association made more than 31 million available to support 354 new and continuing research projects at 144 leading research institutions. The supported projects cover the broad spectrum of research approaches including basic, clinical and translational science and address all types of diabetes, diabetes-related disease states and complications. |
| Form 990, Part III, Line 4 Continued | The primary goals of the Associations Research Program are |
| Form 990, Part III, Line 4 Continued | Support the highest quality science across the broad spectrum of diabetes research. |
| Form 990, Part III, Line 4 Continued | Support investigators early in their careers to encourage them to dedicate their efforts to diabetes research. |
| Form 990, Part III, Line 4 Continued | Support innovative research with a high potential to have a significant impact for patients with diabetes. |
| Form 990, Part III, Line 4 Continued | Peer Review Process |
| Form 990, Part III, Line 4 Continued | One of the factors that sets American Diabetes Association-funded research apart and ensures that we are supporting the very best science is peer review. Peer review is a process whereby grant applications are reviewed and evaluated by individuals who are experts in the field or peers of the individual submitting the grant. Association grant applications all undergo peer review by three or more volunteer experts who are themselves diabetes researchers. Reviewers provide both a score and detailed comments regarding the strengths and weaknesses of each grant they review. Scores from all reviewers for each grant are averaged to arrive at a composite merit score that is then used to determine which grants to support. |
| Form 990, Part III, Line 4 Continued | Types of Research Awards |
| Form 990, Part III, Line 4 Continued | Research awards are divided into four major categories that reflect our research goals and priorities, provide extraordinary opportunities for researchers from diverse backgrounds, and foster the professional development of young scientists interested in diabetes research. The categories are Investigator-Initiated Awards Core Program Pathway to Stop Diabetes Collaborative Targeted Research and Research Co-Support. Approximately 80 percent of American Diabetes Association-funded research falls under the Core Research Awards. In 2015, the Association moved to a single annual grant application cycle for its Core Research Program, featuring a streamlined grant portfolio. A total of 729 research grant applications were submitted. From those applications, 35 post-doctoral fellowships and 50 research and development grants were selected for funding. |
| Form 990, Part III, Line 4 Continued | Research Program Outcomes |
| Form 990, Part III, Line 4 Continued | According to a 2015 retrospective Outcomes Research survey, American Diabetes Association-funded researchers show an exemplary commitment to advancing their careers within the field of diabetes research. Within five years of their award |
| Form 990, Part III, Line 4 Continued | 99 percent remain in diabetes research |
| Form 990, Part III, Line 4 Continued | Average more than five publications per award |
| Form 990, Part III, Line 4 Continued | 92 percent receive subsequent funding to continue their research efforts |
| Form 990, Part III, Line 4 Continued | Subsequent funding amounted to a total of 260.2 million, which is 7.36 for every 1 invested by the American Diabetes Association |
| Form 990, Part III, Line 4 Continued | Pathway to Stop Diabetes |
| Form 990, Part III, Line 4 Continued | Launched in 2013, the American Diabetes Associations Pathway to Stop Diabetes initiative aims to inspire a new generation of diabetes researchers who are early in their career or are established but would like to expand their focus on diabetes research. Through awards of 1.625 million over the course of five to seven years, the program allows researchers to have the time and focus needed to explore new ideas. With a goal of funding 100 new diabetes researchers over the next decade, Pathway provides crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to new discoveries in diabetes prevention and treatment. Importantly, Pathway is in addition to ongoing Association research activities and is significantly expanding our research efforts. |
| Form 990, Part III, Line 4 Continued | Six new Pathway scientists began their research projects in January 2015. During the 2015 calendar year these new awardees, along with the initial five Pathway scientists, collectively published nine high-impact publications, gave more than 40 presentations at scientific meetings, presented 32 invited lectures and filed one patent application. Two Pathway Scientists earned faculty promotions. This level of accomplishment from just 11 individuals is exceptional. The second annual Pathway to Stop Diabetes Symposium was held at the American Diabetes Associations 75th Scientific Sessions in Boston, bringing together the Mentor Advisory Group, program sponsors and Association leadership to meet the Pathway scientists and hear firsthand about their exciting projects and discoveries. The third annual Pathway to Stop Diabetes grant competition also took place in 2015. The Mentor Advisory Group reviewed 103 outstanding nominations and selected six new Pathway Awardees who began their grants in January 2016. These new awardees bring the Pathway scientist cohort up to 17 outstanding investigators. |
| Form 990, Part III, Line 4 Continued | 2015 Research Highlights |
| Form 990, Part III, Line 4 Continued | American Diabetes Association-supported researchers made significant progress in understanding how diabetes develops and progresses, and in identifying new ways to combat the disease. Notable advances include the development of a smart insulin patch that uses nanotechnology to successfully regulate blood glucose levels in laboratory mice studies uncovering new links between cognitive health and prediabetes and a better understanding of how diabetes during pregnancy affects the offsprings health. Boehringer Ingelheim provided support for a targeted research initiative addressing unmet research needs in the area of treating diabetes in the setting of chronic kidney disease and renal insufficiency. This initiative resulted in 81 submissions, and three grants were awarded in April 2015 that will build the evidence base informing clinical practice for people with diabetes complicated by kidney disease. |
| Form 990, Part III, Line 4 Continued | Headlines from Projects Supported by the American Diabetes Association Research Program in 2015 |
| Form 990, Part III, Line 4 Continued | Research to Identify and Correctly Treat Rare Forms of Diabetes |
| Form 990, Part III, Line 4 Continued | Pathway to Stop Diabetes Scientist Generates Smart Insulin Patch |
| Form 990, Part III, Line 4 Continued | Aerobic Exercise Improves Brain Function for People with Prediabetes |
| Form 990, Part III, Line 4 Continued | Study Uncovers Potential New Ways to Prevent Beta Cell Death in Type 2 Diabetes |
| Form 990, Part III, Line 4 Continued | Older Adults Motivated to Make Lifestyle Changes |
| Form 990, Part III, Line 4 Continued | Improving Pregnancy Outcomes in Obese Mothers Starts with Healthy Eggs |
| Form 990, Part III, Line 4 Continued | Very Low Effort Muscular Activity and Diabetes Risk |
| Form 990, Part III, Line 4 Continued | The Diabetes-Depression Connection |
| Form 990, Part I, Line 4 Continued | Scientific Sessions |
| Form 990, Part III, Line 4 Continued | Held annually, Scientific Sessions exemplifies the American Diabetes Associations leadership role in the global diabetes community, while providing a critical platform for driving diabetes awareness. Scientific Sessions is the worlds largest scientific and medical meeting focused on the latest basic and clinical science research related to diabetes and its complications. The 75th Scientific Sessions in Boston showcased the American Diabetes Associations 75th Anniversary. A special exhibit highlighted the history of the American Diabetes Association and of diabetes treatment and care over the past 75 years. With a total attendance of more than 18,000, the meeting met its programmatic and financial goals, while generating more than 17 billion audience media impressions worldwide. A record-breaking number of abstracts regular and late-breaking combined were received for a total of more than 3,600. |
| Form 990, Part VI, Section A, Line 1a | The main responsibilities and focus of the Foundations Board is to advance, support, and promote charitable contributions by soliciting major gifts for the purpose of funding the American Diabetes Associations Nationwide Research Program. The Board of Directors of the Foundation provides governance over the activities of the Foundation in accordance with the purposes, policies, and procedures of the American Diabetes Association. The Board delegates to the Foundations Executive Committee responsibility for management of the Foundation when the Board is not in session. The American Diabetes Association provides complete operational support to the Foundation including staff, facilities and administrative processes. The Foundations annual budget and audit process are governed by the American Diabetes Association Board of Directors and Audit Committee. |
| Form 990, Part VI, Section A, Line 3,7a,7b | The Foundations affairs are managed by the Foundations Board of Directors. The Board of Directors of the Foundations supervises, directs, and controls the activities of the Foundation in accordance with the mission, purposes, policies and procedures of the American Diabetes Association. The Board delegates to the Foundations Executive Committee responsibility for management of the Foundation when the Board is not in session. The American Diabetes Association provides complete operational support to the Foundation including staff, facilities and administrative processes. The Foundations annual budget and audit process are governed by the American Diabetes Association Board of Directors and Audit Committee. If a vacancy occurs among the Foundations officers for any reason, the Board of Directors of the American Diabetes Association shall fill such position for the unexpired portion of the term. |
| Form 990, Part VI, Section B, Line 11a | IRS Form 990 Review Process by the Governing Body |
| Form 990, Part VI, Section B, Line 11a Continued | The American Diabetes Association Research Foundation the Foundation draft IRS 990 is reviewed by the American Diabetes Associations Audit Committee. The final and signed IRS from 990 was provided to the Associations Board of Directors prior to filing with the IRS. |
| Form 990, Part VI, Section B, Line 12 | Managing a Conflict of Interest |
| Form 990, Part VI, Section B, Line 12c Continued | To identify potential conflicts of interest with appropriate due diligence, the Foundations Officers, Directors, and members of the Grant Review Panel must annually disclose any potential conflicts of interest. The American Diabetes Associations Audit Committee and senior staff in legal affairs manage the disclosure and monitoring processes of the Board. The senior staff on the Associations Scientific and Medical Division manage the disclosure and monitoring processes of the Grant Review Panel. |
| Form 990, Part VI, Section B, Line 11a | Through review of the annual disclosures and review of the agendas of relevant Board, Committee and other meetings, appropriate efforts are made in advance of the meetings to identify potential conflicts of interest. Each person also has the responsibility to report his/her own conflicts of interest actual or perceived as those conflicts may arise during a meeting. |
| Form 990, Part VI, Section B, Line 12c | Research Grants Review Committee |
| Form 990, Part VI, Section B, Line 12c | Conflict of Interest COI within the Research Grants Review Committee is managed through a written COI policy and through COI declarations signed both before and after the review cycle. The COI for grant reviewers is self-reported. The primary considerations addressed in the COI policy and program guidelines are as follows - Institutional Individuals are required to recuse themselves from reviewing grants for scientists at the same institution, including any institutions with which they may be negotiating employment. - Financial Individuals are required to recuse themselves from reviewing grants from which they stand to gain financially if the grant is awarded co-PI, collaborator, subcontracts, etc.. Personal Individuals are required to recuse themselves from reviewing grants for investigators with whom they either have a personal or professional relationship collaborators, colleagues or personal friends, or a long standing professional or scientific disagreement that prevents them from unbiased review. |
| Form 990, Part VI, Section B, Line 13 | The American Diabetes Association has a written whistleblower policy that applies to the American Diabetes Association Research Foundation. |
| Form 990, Part VI, Section B, Line 14 | The American Diabetes Association has a written Document Retention and Destruction policy that applies to the American Diabetes Association Research Foundation. |
| Form 990, Part VI, Section c, Line 17 | Filing Jurisdiction-Registration Number Filing Jurisdiction-Registration Number Alabama AL97-256 Minnesota N/A Alaska N/A Mississippi 100000294 Arkansas N/A New Hampshire 5006 California CT81471 New Jersey CH-0581900 Colorado 2002-3003670 New Mexico N/A Connecticut 5084 New York 01/30/65 District of Columbia 981855 North Carolina SL000618 Florida CH1618 North Dakota 7894 Georgia CH-001422 Ohio 01-0239 Hawaii N/A Oklahoma N/A Illinois CO 01-025537 Oregon 16402 Indiana 000103829-000 Pennsylvania No. 21 Kansas 177-257-3SO Rhode Island 95-233 Kentucky 45 South Carolina 641 Louisiana N/A Tennessee 5104 Maine CO-1247 Utah 6536093-Char Maryland 102 Virginia N/A Massachusetts O29317 Washington 7664 Michigan MICS 10326 West Virginia N/A Wisconsin 3020-800 |
| Form 990, Part VI, Section C, Line 19 | Document Disclosure The following documents are available on the American Diabetes Association website http//www.diabetes.org Board of Directors, audited Foundation financial statements, IRS Forms 990, and the whistleblower policy. Available subject to request to the American Diabetes Association Legal Affairs department are the following current bylaws, Articles of Incorporation, and the conflict of interest policy. |
| Form 990, Part VII, Section A, Line 4,17,18 | The Chief Executive Officer is a non-voting member of the Research Foundation Board of Directors. The Chief Executive Officer, the Chief Financial Officer, and the Chief Scientific Medical Officer are compensated by the American Diabetes Association based on a standard average of 38 hours per week. |
| Form 990, Part VII, Section A, Line 4,15 and 16 | Kevin L. Hagan began his tenure as Chief Executive Officer of the American Diabetes Association effective June 1, 2015. Deborah L. Johnson, Chief Financial Officers employment ended October 13, 2015. M. Suzanne C. Berry, Interim Chief Executive Officer term was from August 1, 2014 to February 28, 2015. |
| Form 990, Part XI, Line 9 | Other changes in net assets or fund balances of 810,820 reflect prior year research grant award refunds and forfeitures. |
| Software ID: | 15000290 |
| Software Version: | 15.3.0.0 |